Peoples Financial Services Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-200
Closed -$2K 300
2020
Q4
$2K Hold
200
﹤0.01% 280
2020
Q3
$2K Hold
200
﹤0.01% 275
2020
Q2
$2K Hold
200
﹤0.01% 288
2020
Q1
$2K Hold
200
﹤0.01% 297
2019
Q4
$2K Hold
200
﹤0.01% 319
2019
Q3
$1K Hold
200
﹤0.01% 346
2019
Q2
$2K Hold
200
﹤0.01% 341
2019
Q1
$3K Hold
200
﹤0.01% 311
2018
Q4
$3K Hold
200
﹤0.01% 311
2018
Q3
$4K Hold
200
﹤0.01% 313
2018
Q2
$5K Hold
200
﹤0.01% 282
2018
Q1
$3K Buy
+200
New +$3.9K ﹤0.01% 322
2014
Q1
Sell
-4,000
Closed -$160K 353
2013
Q4
$160K Buy
+4,000
New +$158K 0.11% 111

Other funds holding TEVA

Peoples Financial Services Corp's TEVA Position: Q1 2021 in Review

Peoples Financial Services Corp sold out of Teva Pharmaceuticals (TEVA) in Q1 2021, closing a stake of 200 shares — an estimated $2K sold.

Peoples Financial Services Corp first reported a position in TEVA in Q4 2013 and held it in 13 quarters. The position peaked at $160K in Q4 2013. 451 funds tracked by Wall St. Rank hold TEVA as of Q1 2021.

  • Peoples Financial Services Corp reported no remaining Teva Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Peoples Financial Services Corp sold 200 Teva Pharmaceuticals shares in Q1 2021, an estimated $2K.
  • Peoples Financial Services Corp first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 13 quarters.
  • Peoples Financial Services Corp's Teva Pharmaceuticals position peaked at $160K in Q4 2013.
  • 451 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2021.

Based on Peoples Financial Services Corp's 13F filing for Q1 2021, filed 15 Apr 2021.